Hemokinin-1 Molecular Adjuvant: An Approach to Enhance the Efficacy of Influenza Vaccine

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Arak Medical University Journal

• Publication date

  2015-02-15

• Fields of study

  Biology, Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Innate Immune Signaling by, and Genetic Adjuvants for DNA Vaccination

  2013cited by this paper
• Predictive markers of safety and immunogenicity of adjuvanted vaccines.

  2013cited by this paper
• Working together: interactions between vaccine antigens and adjuvants

  2013cited by this paper
• Nucleic acid sensing at the interface between innate and adaptive immunity in vaccination

  2012cited by this paper
• Hemokinin-1 Gene Expression Is Upregulated in Microglia Activated by Lipopolysaccharide through NF-κB and p38 MAPK Signaling Pathways

  2012cited by this paper
• Tachykinins Stimulate a Subset of Mouse Taste Cells

  2012cited by this paper
• Hemokinin-1 As an Adjuvant Molecule Enhancing Humoral and Memory Responses to HBsAg DNA Vaccination

  2012cited by this paper
• Molecular Adjuvant Ag85A Enhances Protection against Influenza A Virus in Mice Following DNA Vaccination

  2012cited by this paper
• Selection of Adjuvants for Enhanced Vaccine Potency

  2011cited by this paper
• Expression and proliferative effect of hemokinin-1 in human B-cells.

  2011cited by this paper
• Molecular adjuvant HMGB1 enhances anti-influenza immunity during DNA vaccination

  2011cited by this paper
• New developments in vaccine research--unveiling the secret of vaccine adjuvants.

  2011cited by this paper
• Hemokinin-1 Activates the MAPK Pathway and Enhances B Cell Proliferation and Antibody Production

  2010cited by this paper
• New adjuvants for human vaccines.

  2010cited by this paper
• Mechanism of action of clinically approved adjuvants.

  2009cited by this paper
• Vaccine adjuvants and delivery systems

  2007cited by this paper
• Avian flu: Influenza virus receptors in the human airway

  2006cited by this paper
• IC31, a novel adjuvant signaling via TLR9, induces potent cellular and humoral immune responses.

  2006cited by this paper
• Influenza Virus: Immunity and Vaccination Strategies. Comparison of the Immune Response to Inactivated and Live, Attenuated Influenza Vaccines

  2004cited by this paper
• The Roles of Toll-Like Receptor 9, MyD88, and DNA-Dependent Protein Kinase Catalytic Subunit in the Effects of Two Distinct CpG DNAs on Dendritic Cell Subsets1

  2003cited by this paper
• T-cell developmental blockage by tachykinin antagonists and the role of hemokinin 1 in T lymphopoiesis.

  2003cited by this paper
• CpG ODN can re-direct the Th bias of established Th2 immune responses in adult and young mice.

  2001cited by this paper
• Improving vaccine performance with adjuvants.

  2000cited by this paper
• Hemokinin is a hematopoietic-specific tachykinin that regulates B lymphopoiesis

  2000cited by this paper
• CpG DNA as a Th1 Trigger

  2000cited by this paper

• Evaluation of Immune Responses Induced by Co-administration of Recombinant NP-based Influenza H1N1 Vaccine and Hemokinin-1 Adjuvant in BALB/c Mice

  2019cites this paper
• ارزیابی پاسخ های ایمنی القاء شده علیه تجویز هم زمان پروتئین نوترکیب NP ویروس آنفلوانزا H1N1 و یاور هموکینین-1 در موش های BALB/c

  2019cites this paper
• virus genetic variations, evade from immune system

  2018cites this paper
• Improvement Efficacy of Influenza Nanovaccine in Combination with Hemokinin-1 Molecular Adjuvant

  2018cites this paper
• Improvement influenza HA2 DNA vaccine cellular and humoral immune responses with Mx bio adjuvant.

  2017cites this paper
• Challenges and Perspectives towards the Development of more Effective Influenza Vaccine

  2017cites this paper
• MX BIO ADJUVANT FOR ENHANCING IMMUNE RESPONSES AGAINST INFLUENZA VIRUS

  2015cites this paper
• Advanced Pharmaceutical Bulletin In Silico Analysis of HA 2 / Mx Chimera Peptide for Developing an Adjuvanted Vaccine to Induce Immune Responses Against Influenza Viruses

  2015cites this paper
• In Silico Analysis of HA2/Mx Chimera Peptide for Developing an Adjuvanted Vaccine to Induce Immune Responses Against Influenza Viruses.

  2015cites this paper
• A Review: Evaluating the Dynamics of Influenza Viruses Replication and Host Cell- Virus Interactions

  2015cites this paper